Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ariella who wrote (289)	12/6/1998 8:37:00 AM
From: crysball	Read Replies (2) of 1386

Regarding the HU-211 strategic alliance for PH3 Ariella and/or Neuroinvestor would you identify the candidates in Ariella's Category 2 (those companies with failed TBI products)and Category 3 (those companies with a hole in their product line).....which as Ariella points out may not be mutually exclusive? Also, do you anticipate the prospective partner will tie up HU-211 for stroke indication as part of their TBI negotiation.........or will PARS hold this (and other indications) off the negotiating table for future potential alliances? Is there a potential category 3 alliance partner who lacks both a TBI drug and a stroke drug .......if so would you identify them? Ariella your analysis and humor are greatly appreciated. I also will be bidding if prices reach the 1 5/8 region. Patiently, Neil

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next